ProcessIntermediate
What is the recommended cervical cancer screening interval for individuals aged 21-29 years according to the guidelines for transgender and gender expansive adults?
The recommended cervical cancer screening interval for individuals aged 21-29 years is cervical cytology every 3 years.
For individuals aged 21-29 years with a cervix, the guidelines recommend cervical cytology (Pap test) every 3 years. This recommendation applies to transgender and gender expansive adults who have a cervix, aligning with general cervical cancer screening guidelines for this age group.
Key points
- Cervical cytology every 3 years for ages 21-29.
- Applies to individuals with a cervix, including transgender and gender expansive adults.
- Aligns with general cervical cancer screening guidelines.
Source:Collins-Bride & Saxe’s Clinical Guidelines for Advanced Practice Nursing· Healthcare Maintenance for Transgender and Gender Expansive (TGE) Adults· p. 837–841
Collins-Bride & Saxe’s Clinical Guidelines for Advanced Practice Nursing
Joo, Yoonmee;Gatewood, J. V.;Israel, Mary Anne M.;Wong McGrath, Kelly;
FOURTH EDITION · Jones & Bartlett Learning